CD274 and neoplasm: Based on PD-L1 staining intensities in tumor samples, no staining (0) and weak staining (1+) specimens were classified as PD-L1-low patients (57.1%); moderate staining (2+) and intense staining (3+) specimens were classified as PD-L1-high patients (42.9%) (Figure 2A).